Skip to Main Content

A 20-year-old college student was seen for fatigue and an upper respiratory infection and started on amoxicillin for a sore throat. Six days later she broke out with a red rash all over her body (Figure 203-1). She went to see her family physician back home with the rash and lymphadenopathy. A monospot was drawn and found to be positive. This morbilliform rash (like measles) is typical of an amoxicillin drug eruption in a person with mononucleosis. Amoxicillin was stopped, and diphenhydramine was used for the itching.

Figure 203-1

Amoxicillin rash in a young woman with mononucleosis. This is a morbilliform eruption. (Courtesy of Richard P. Usatine, MD.)

Cutaneous drug reactions are skin manifestations of drug hypersensitivity. Drug hypersensitivity may be defined as symptoms or signs initiated by a drug exposure at a dose normally tolerated by nonhypersensitive persons.1 Drug-induced adverse reactions are often classified as type A and type B. Type A reactions are common (80%) predictable side effects caused by a pharmacologic action of the drug, and type B reactions are uncommon (10% to 15%) and considered idiosyncratic, a result of individual predisposition (e.g., an enzyme defect).2 Cutaneous drug reactions range from mild skin eruptions (e.g., exanthem, urticaria, and angioedema) to severe cutaneous drug reactions (SCARs), the latter category including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome (DIHS).3

Cutaneous adverse reactions, drug reactions, medication reactions, adverse effects to drugs, hypersensitivity reactions.

  • Cutaneous drug reactions are common complications of drug therapy occurring in 2% to 3% of hospitalized patients.4
  • One study found that 45% of all adverse drug reactions were manifested in the skin.4
  • Approximately 1 in 6 adverse drug reactions represents drug hypersensitivity, and are allergic or non-immune-mediated (pseudoallergic) reactions.2
  • Maculopapular eruptions, also known as exanthematous drug eruptions, are the most frequent of all cutaneous drug reactions, representing 95% of skin reactions.5 They are often confused with viral exanthems. This occurs most commonly with β-lactams such as amoxicillin, but also with barbiturates, gentamicin, isoniazid, phenytoin, sulfonamides, thiazides, and trimethoprim-sulfamethoxazole (Figures 203-1 and 203-2).
  • Urticarial drug reactions are the second most common skin eruptions, representing approximately 5% of cutaneous drug reactions.5 This reaction can result from any drug but commonly occurs with aspirin, penicillin, sulfa, angiotensin-converting enzyme (ACE) inhibitors, aminoglycosides, and blood products. Urticaria results from immunoglobulin (Ig) E reactions within minutes to hours of drug administration (Figures 203-3 and 203-4).
  • Drug-induced hyperpigmentation occurs with antiarrhythmics (amiodarone), antibiotics (minocycline), NSAIDs, and chemotherapy agents (Adriamycin) (Figure 203-5).
  • Warfarin-induced skin necrosis (WISN) is a rare but serious side effect predominantly seen in obese women and presents between days 3 and 6 of warfarin treatment. WISN is more common in those with thrombophilic abnormalities, given ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.